Olmin 20-A Tablet
By Olmin A
Rx
15 Tablet in a Strip

Composition
Olmesartan Medoxomil(20mg) + Amlodipine(5mg)

Manufacturer - Eris Lifesciences Ltd
8th Floor, Commerce House IV, Prahladnagar, Ahmedabad – 380015 Gujarat, India

Expires on or after
November, 2027

liver
Olmin 20-A Tablet needs to be approached with caution in individuals with liver conditions. It's important to note that patients with liver disease may require a dosage adjustment when taking Olmin 20-A Tablet. It is advised to consult your doctor before using this medication. In cases where a patient has liver issues, the initiation of Olmin 20-A Tablet should begin at a lower dose and then be gradually increased while closely monitoring the patient's condition to ensure safety and efficacy.

kidney
Olmin 20-A Tablet needs caution in severe kidney disease. Dose adjustment may be necessary. Consult your doctor. Monitor blood pressure regularly.

alcohol
It is not safe to drink alcohol while taking Olmin 20-A Tablet.

driving
Olmin 20-A Tablet may cause side effects like dizziness, headaches, nausea, or tiredness, which may impair your ability to drive. Be cautious as these effects can affect concentration and driving ability.

pregnancy
Olmin 20-A Tablet is not safe to use during pregnancy due to the risk to the developing baby. Only in life-threatening situations, a doctor might prescribe it if benefits outweigh risks. Consult your doctor before using.

breastfeeding
Olmin 20-A Tablet may not be safe during breastfeeding. Limited data shows it may pass into breastmilk and harm the baby.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | CARDIAC |
| Action Class | - |
₹263.08
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024



